STAT August 1, 2024
Regenxbio said Thursday that its experimental gene therapy for Duchenne muscular dystrophy was administered to two more boys and produced high levels of a miniaturized version of the protein needed for muscles to function properly.
The updated results from an early study suggest the Regenxbio therapy,...